The NIHR Manchester Biomedical Research Centre (BRC) transforms scientific breakthroughs into diagnostic tests and life-saving treatments for patients.
Awarded £64.1 million (2022-28) – the largest single research award given by the National Institute for Health and Care Research (NIHR) to the city region – the NIHR Manchester BRC is driving forward pioneering research in the areas of:
- Cancer (prevention and early detection, advanced radiotherapy, precision medicine, living with and beyond cancer)
- Inflammation (rheumatic and musculoskeletal disease, respiratory medicine, dermatology, integrative cardiovascular medicine)
- Under-researched conditions (hearing health, mental health, rare conditions)
- Advanced diagnostics and therapeutics (next generation phenotyping and diagnostics, next generation therapeutics).
NIHR Biomedical Research Centres (BRCs) are collaborations between NHS organisations and universities. They bring together academics and clinicians to translate scientific discoveries into potential new treatments, diagnostics and technologies.
Manchester BRC is hosted by Manchester University NHS Foundation Trust and The University of Manchester – in partnership with five NHS trusts; Blackpool Teaching Hospitals NHS Foundation Trust, The Christie NHS Foundation Trust, Greater Manchester Mental Health NHS Foundation Trust, Lancashire Teaching Hospitals NHS Foundation Trust, and the Northern Care Alliance NHS Foundation Trust.
NIHR Manchester BRC website
Visit the NIHR Manchester BRC website for more information about how researchers are rapidly translating research to bring major health benefits to a diverse global population.
